Oncimmune signs contracts with US-based clinical-stage biopharmaceutical companies developing immunotherapies one of which is focused on CAR NK cell therapies. April 8, 2022 9:06 am
April 28, 2023 3:04 pm
April 8, 2022 9:06 am
